Jan Tebbe
17Patents
4h-index
67Co-inventors
63Inventor score
Filing activity: Dec 19, 1996 → Feb 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8399627B2 | Antibodies to TNFα | Chemistry; Metallurgy | 15 | Active |
| US10973923B2 | Site specific homogeneous with KSP inhibitors | Chemistry; Metallurgy | 8 | Active |
| US5753378A | Laminated structural material and method for producing same | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8481030B2 | Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) | Chemistry; Metallurgy | 7 | Active |
| US10597674B2 | HPPD variants and methods of use | Chemistry; Metallurgy | 2 | Active |
| US9657111B2 | Humanized monoclonal antibodies against activated protein C and uses thereof | Physics | 2 | Active |
| US9309324B2 | Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) | Chemistry; Metallurgy | 2 | Active |
| US11578323B2 | RNA-programmable endonuclease systems and their use in genome editing and other applications | Chemistry; Metallurgy | 1 | Active |
| US12390508B2 | Brain natriuretic peptide engrafted antibodies | Chemistry; Metallurgy | 0 | Active |
| US12331094B2 | Atrial natriuretic peptide engrafted antibodies | Chemistry; Metallurgy | 0 | Active |
| USRE47150E1 | Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) | General | 0 | Active |
| US9534046B2 | Antibodies to TNFα | Chemistry; Metallurgy | 0 | Active |
| US11371056B2 | HPPD variants and methods of use | Chemistry; Metallurgy | 0 | Active |
| USRE49099E1 | Humanized monoclonal antibodies against activated protein c and uses thereof | General | 0 | Active |
| US11180770B2 | HPPD variants and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11806404B2 | Site specific homogeneous with KSP inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12203110B2 | RNA-programmable endonuclease systems and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.